_________
false
C002
טבע תעשיות פרמצבטיות בע"מ
2
Public
TEVA- PHARMACEUTICAL INDUSTRIES LTD.
7217
Corporation no:
520013954
Stock Exchange/Market:
טבע
310
380
P.O.B
3190
,
Petach Tikva
49131
,
,
Tel:
03-9267267
,
03-9267652
Fax:
03-9267519
E.mail address:
elana.holzman@teva.co.il
Date of transmission:
02/01/2012
Time of broadcast:
05:56
05:34:58
Reference:
2012-02-002298
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
TEVA ANNOUNCES MANAGEMENT SUCCESSION Dr. Jeremy Levin, A Former Senior Executive at Bristol-Myers Squibb, To Succeed Shlomo Yanai as President and CEO
SYJLpressrelease010112final_isa.pdf
Please find attached a press release and its non binding Hebrew translation, provided for convenience purposes only.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure:
29/12/2011
Name of the Signatory:
:
Desheh Eyal
,
Position of Signatory in the reporting corporation:
Chief Financial Officer
,
Name of Employer Company:
.
Basel
Telephone:
02-9411717
,
Facsimile:
02-9411718
,
E-mail:
elana.holzman@teva.co.il
2